Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
CORTISPORIN OINTMENT |
| Manufacturer |
|
King Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Steroid + antibiotics. |
| Generic Name |
|
Hydrocortisone 1%, polymyxin B (as sulfate) 5000 Units/g, neomycin (as sulfate) 0.35%, bacitracin (as zinc) 400 Units/g. |
| Also |
|
• CORTISPORIN
|
| Indications |
|
Short-term use in corticosteroid-responsive dermatoses with secondary infection. |
| Children |
|
Not recommended. |
| Adults |
|
Apply sparingly and massage in 2–4 times daily. |
| Contraindications |
|
Do not use in eyes, external ear canal if eardrum perforated. Tuberculous, fungal, or viral lesions. |
| Precautions |
|
Intertrigo, diaper or stasis dermatitis or ulceration, extensive burns (neomycin may be absorbed). Avoid prolonged use or on large areas. Use lowest effective dose. Monitor for HPA axis suppression; avoid abrupt cessation if used for chronic conditions. Discontinue if infection persists or worsens or if superinfection occurs. Occlusion: not recommended. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Local irritation, folliculitis, hypertrichosis, dermatitis, sensitization, ototoxicity, nephrotoxicity (if neomycin is significantly absorbed), HPA axis suppression (esp. in children), epidermal and dermal atrophy (esp. in thin-skinned or occluded areas). |
| How Supplied |
Crm—7.5g
Oint—½oz |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
